Loading viewer...
investor_presentation
Format: PDF investor_presentation
Webcast and Conference Call February 4, 2021 U.S. toll -free +1-833-968 -1955 International toll +1-647-689 -6656 Conference ID: 3288725Phibro Animal Health Corporation Financial Results Second Quarter -ended December 31, 2020 Fiscal Year 2021
Webcast and Conference Call
U.S. toll -free +1-833-968 -1955
International toll +1-647-689 -6656
Conference ID: 3288725Phibro Animal Health Corporation
Second Quarter -ended December 31, 2020
Important Information
Cautionary Statement Regarding Forward- Looking Statements
This communication contains forward -looking statements that are subject to risks and uncertainties. All statements other than st atements of historical or current fact included in this report are forward-
looking statements. Forward- looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and
business. You can identify forward- looking statements by the fact that they do not relate strictly to historical or current fact s. These statements may include words such as “aim,” “anticipate,” “estimate,”
“expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “believe,” “may,” “could,” “ would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words
and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performa nce or other events. These statements are not a guarantee of future
performance or actions. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those
contemplated by a forward- looking statement. Forward- looking statements speak only as of the date on which they are made. Phibro expressly disclaims any obligation to update or revise any forward-
looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Quarterly Report on Form
10-Q and Annual Report on Form 10- K, including in the sections thereof captioned “Forward- Looking Statements” and “Risk Factors.” These filings and subsequent filings are available online at
www.sec.gov , www.pahc.com , or on request from Phibro.
Non-GAAP Financial Measures
We use non- GAAP financial measures, such as adjusted EBITDA and adjusted net income, to assess and analyze our operational results and trends and to make financial and operational decisions.
Management uses adjusted EBITDA as its primary operating measure. We report adjusted net income to portray the results of our operations prior to considering certain income statement elements. We
believe these non- GAAP financial measures are also useful to investors because they provide greater transparency regarding our operating performance. The non- GAAP financial measures included in
this communication should not be considered alternatives to measurements required by GAAP, such as net income, operating income, and earnings per share, and should not be considered measures of
Preview truncated — download the full document for the complete content.
investor_presentation
29 Pages
investor_presentation
63 Pages
Kiora Pharmaceuticals
Regency Centers Equity One merger 2016 acquisition
investor_presentationinvestor_presentation
18 Pages
Regency Centers Corporation
investor_presentation
Atreca
investor_presentation
Ocugen